Clinical Trial Update: Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating consolidation with toripalimab plus capecitabine after chemoradiotherapy in esophageal squamous cell carcinoma is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Cancer, Chemoradiotherapy | Phase 3 | Status: RECRUITING